Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc. , according to people with knowledge of the matter.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-07-01/sixth-street-kkr-provide-bridgebio-1-billion-preferred-equity)